Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-01-01 @ 2:06 AM
Study NCT ID:
NCT00649532
Status:
COMPLETED
Last Update Posted:
2024-04-24
First Post:
2008-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fasting Study of Ondansetron Tablets 24 mg and Zofran® Tablets 24 mg
Sponsor:
Mylan Pharmaceuticals Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2003-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-07
Completion Date Type:
ACTUAL
First Submit Date:
2008-03-30
First Submit QC Date:
None
Study First Post Date:
2008-04-01
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-22
Last Update Post Date:
2024-04-24
Last Update Post Date Type:
ACTUAL